The bacteria that cause food poisoning love summer cookouts. So, it is important to keep food safety in mind, especially for people who are receiving or recovering from cancer treatment. Kristina Beaugh, MPH, and Tina Hanes, RD, from the U.S. Department of Agriculture Food Safety and Inspection Service provide tips on making your barbeques and picnics food safe this summer.
First in our summer Research Round Up podcast series, Charles Loprinzi, MD, and Ezra Cohen, MD, unpack some of science highlights from the 2015 ASCO Annual Meeting.
Last week, Lidia Schapira, MD, FASCO, became the new Editor in Chief of Cancer.Net. She has spent her career working to improve communication between patients and doctors and has a distinct vision for the future of Cancer.Net.
In this podcast, experts Charles Ryan, MD, and Thomas Powles, MD, talk about bladder cancer treatment, including some of the new approaches that are being developed.
Is More Extensive Surgery Better for Early-Stage Oral Cancer? – Research from the 2015 ASCO Annual Meeting
Doctors worldwide have struggled with this question for decades. A new study presented today at the 2015 ASCO Annual Meeting provides clarification on whether lymph nodes should be removed before or after cancer has been detected in the nodes of people with early-stage oral cancer.
A recent study shows that people who took a form of vitamin B3 called nicotinamide developed fewer non-melanoma skin cancers. In this podcast, Patricia A. Ganz, MD, discusses this study and what it means for people at risk for skin cancer.
Since the 1970s, we have been involved in a war against cancer. But how do military metaphors and battle imagery affect people who are trying to cope with the challenges of a cancer diagnosis? Longtime patient advocate Diane Blum, MSW, FASCO, explores common language used to describe cancer and its treatment.
In this podcast, experts discuss ASCO’s recent endorsement of ASTRO’s guideline for radiation therapy for non-small cell lung cancer.
Dr. Julie Brahmer from the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins shares details about the recent FDA approval of nivolumab (Opdivo) for advanced non-small cell lung cancer. She explains how this impacts the treatment of lung cancer.
First in this podcast series, Dr. Brian Rini shares his perspective on current and new approaches to kidney cancer treatment.